Paragon 28 (FNA) Competitors $5.62 +0.32 (+6.04%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FNA vs. WRBY, INMD, ESTA, AORT, BLFS, BVS, PLSE, AVNS, MDXG, and LQDAShould you be buying Paragon 28 stock or one of its competitors? The main competitors of Paragon 28 include Warby Parker (WRBY), InMode (INMD), Establishment Labs (ESTA), Artivion (AORT), BioLife Solutions (BLFS), Bioventus (BVS), Pulse Biosciences (PLSE), Avanos Medical (AVNS), MiMedx Group (MDXG), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry. Paragon 28 vs. Warby Parker InMode Establishment Labs Artivion BioLife Solutions Bioventus Pulse Biosciences Avanos Medical MiMedx Group Liquidia Warby Parker (NYSE:WRBY) and Paragon 28 (NYSE:FNA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations, community ranking and media sentiment. Do institutionals and insiders believe in WRBY or FNA? 93.2% of Warby Parker shares are owned by institutional investors. Comparatively, 63.6% of Paragon 28 shares are owned by institutional investors. 26.6% of Warby Parker shares are owned by company insiders. Comparatively, 15.3% of Paragon 28 shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor WRBY or FNA? Warby Parker received 1 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 81.58% of users gave Paragon 28 an outperform vote while only 38.55% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformWarby ParkerOutperform Votes3238.55% Underperform Votes5161.45% Paragon 28Outperform Votes3181.58% Underperform Votes718.42% Does the media refer more to WRBY or FNA? In the previous week, Paragon 28 had 12 more articles in the media than Warby Parker. MarketBeat recorded 20 mentions for Paragon 28 and 8 mentions for Warby Parker. Warby Parker's average media sentiment score of 0.48 beat Paragon 28's score of 0.08 indicating that Warby Parker is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Warby Parker 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Paragon 28 0 Very Positive mention(s) 1 Positive mention(s) 19 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer WRBY or FNA? Warby Parker presently has a consensus target price of $17.30, indicating a potential downside of 0.86%. Paragon 28 has a consensus target price of $15.25, indicating a potential upside of 171.59%. Given Paragon 28's stronger consensus rating and higher possible upside, analysts clearly believe Paragon 28 is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Warby Parker 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60Paragon 28 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is WRBY or FNA more profitable? Warby Parker has a net margin of -6.38% compared to Paragon 28's net margin of -24.64%. Warby Parker's return on equity of -11.09% beat Paragon 28's return on equity.Company Net Margins Return on Equity Return on Assets Warby Parker-6.38% -11.09% -5.87% Paragon 28 -24.64%-32.39%-17.07% Which has preferable valuation and earnings, WRBY or FNA? Paragon 28 has lower revenue, but higher earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Paragon 28, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWarby Parker$669.77M2.62-$63.20M-$0.39-44.74Paragon 28$216.39M2.17-$57.53M-$0.69-8.14 Which has more risk and volatility, WRBY or FNA? Warby Parker has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, Paragon 28 has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. SummaryWarby Parker beats Paragon 28 on 12 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… Get Paragon 28 News Delivered to You Automatically Sign up to receive the latest news and ratings for FNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FNA vs. The Competition Export to ExcelMetricParagon 28Surgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$469.08M$4.45B$5.33B$19.25BDividend YieldN/A41.87%5.07%3.53%P/E Ratio-8.1444.53128.5743.31Price / Sales2.1760.861,489.0014.53Price / CashN/A49.3439.6220.89Price / Book2.744.264.765.40Net Income-$57.53M$11.52M$118.92M$985.39M7 Day Performance14.83%1.06%0.79%-0.71%1 Month Performance-5.47%0.92%5.63%-0.97%1 Year Performance-40.42%39.37%36.69%25.05% Paragon 28 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FNAParagon 282.4163 of 5 stars$5.62+6.0%$15.25+171.4%-38.0%$469.50M$216.39M-8.14343,000Gap UpWRBYWarby Parker2.3236 of 5 stars$17.34+2.5%$17.00-2.0%+40.6%$1.75B$719.93M-44.463,491Upcoming EarningsAnalyst ForecastNews CoverageINMDInMode3.6174 of 5 stars$18.05+0.8%$22.60+25.2%-9.3%$1.52B$416.63M10.37480Analyst ForecastNews CoverageESTAEstablishment Labs1.9871 of 5 stars$44.56-0.6%$58.83+32.0%+44.0%$1.25B$151.35M-14.33960Upcoming EarningsShort Interest ↑News CoverageAORTArtivion2.038 of 5 stars$27.03+1.1%$30.60+13.2%+107.6%$1.13B$376.97M-128.711,500Upcoming EarningsNews CoverageBLFSBioLife Solutions1.3246 of 5 stars$24.00+1.7%$26.67+11.1%+135.3%$1.11B$139.96M-14.20409News CoverageBVSBioventus1.7495 of 5 stars$13.60+2.2%$12.00-11.8%+276.2%$1.10B$536.89M-20.611,200Upcoming EarningsPLSEPulse Biosciences1.2205 of 5 stars$17.43+2.3%N/A+232.4%$1.07B$700,000.00-21.52140Earnings ReportNews CoverageAVNSAvanos Medical3.4953 of 5 stars$19.15-15.4%N/A-10.0%$879.92M$682.40M112.653,771News CoverageMDXGMiMedx Group4.0174 of 5 stars$5.78-0.5%$12.00+107.6%+7.4%$848.56M$340.46M10.32870Analyst UpgradeAnalyst RevisionNews CoverageLQDALiquidia3.8771 of 5 stars$11.02-0.2%$24.67+123.8%+66.6%$846.27M$14.84M-7.0250Upcoming Earnings Related Companies and Tools Related Companies WRBY Competitors INMD Competitors ESTA Competitors AORT Competitors BLFS Competitors BVS Competitors PLSE Competitors AVNS Competitors MDXG Competitors LQDA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:FNA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Paragon 28, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Paragon 28 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
